C34H30FN7O9S — CID 156507840
4-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]amino]-N-[2-[8-fluoro-6-hydroxy-7-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]oxyethyl]benzamide (PubChem CID 156507840) has the molecular formula C34H30FN7O9S and a molecular weight of 731.72 g/mol. Its IUPAC name is 4-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]amino]-N-[2-[8-fluoro-6-hydroxy-7-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]oxyethyl]benzamide.
| Compound Name | 4-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]amino]-N-[2-[8-fluoro-6-hydroxy-7-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]oxyethyl]benzamide |
|---|---|
| PubChem CID | 156507840 |
| Molecular Formula | C34H30FN7O9S |
| Molecular Weight | 731.72 g/mol |
| Exact Mass | 731.18 |
| IUPAC Name | 4-[[1-(2,6-dioxopiperidin-3-yl)-3-methyl-2-oxobenzimidazol-5-yl]amino]-N-[2-[8-fluoro-6-hydroxy-7-(1,1,4-trioxo-1,2,5-thiadiazolidin-2-yl)naphthalen-2-yl]oxyethyl]benzamide |
| SMILES | Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(Nc3ccc(C(=O)NCCOc4ccc5cc(O)c(N6CC(=O)NS6(=O)=O)c(F)c5c4)cc3)cc21 |
| InChI | InChI=1S/C34H30FN7O9S/c1-40-26-15-21(7-9-24(26)42(34(40)48)25-10-11-28(44)38-33(25)47)37-20-5-2-18(3-6-20)32(46)36-12-13-51-22-8-4-19-14-27(43)31(30(35)23(19)16-22)41-17-29(45)39-52(41,49)50/h2-9,14-16,25,37,43H,10-13,17H2,1H3,(H,36,46)(H,39,45)(H,38,44,47) |
| InChIKey | FLFLQRJHNZICDC-UHFFFAOYSA-N |
| XLogP | 2.05 |
| TPSA | 210.17 Ų |
| H-Bond Donors | 5 |
| H-Bond Acceptors | 12 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 52 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 731.72 |
| LogP ≤ 5 | 2.05 |
| H-Bond Donors ≤ 5 | 5 |
| H-Bond Acceptors ≤ 10 | 12 |
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'} |
|---|